Validation platform allows local hospitals to determine how well AI systems would detect breast cancer

While there are currently a dozen approved AI systems for breast cancer screening, it has been difficult to evaluate their clinical performance objectively. Now, however, there is a Swedish validation platform ready to compare how well AI systems detect signs of breast cancer—and its development has been led by researchers at Karolinska Institutet.